Goldman Sachs Upgrades Indian Equities, Sets Nifty50 Target at 29,000


|

Goldman Sachs Upgrades Indian Equities, Sets Nifty50 Target at 29,000
Goldman Sachs Upgrades Indian Equities, Sets Nifty50 Target at 29,000
Goldman Sachs raises Indian equities to 'overweight' with a Nifty50 target of 29,000 by the end of 2026, signalling potential growth.

Goldman Sachs has expressed renewed optimism regarding the Indian stock market, elevating its rating to 'overweight' and establishing a target of 29,000 for the Nifty50 index by the end of 2026. This projection indicates a potential rise of around 14% from the index's recent closing value of 25,492.

The financial firm has noted that the Indian equity market has underperformed this year, marking its most significant decline in two decades, despite a robust performance by emerging markets overall, which saw a 30% increase.

According to Goldman Sachs, the limited growth of Indian equities, which increased by just 3% in US dollar terms this year, suggests a turning point may be on the horizon. "With a year-long earnings downgrade cycle stabilising in the past few months and showing signs of recovery, coupled with our expectations of policy-driven easing financial conditions going forward, we now see a case for Indian equities to perform better over the coming year and moderate its significant underperformance versus the region," the firm stated in a recent client communication.

In its analysis, Goldman Sachs has highlighted a selection of companies recommended for investment, including Apollo Hospitals, KEI Industries, PTC Industries, MakeMyTrip, UNO Minda, Hitachi Energy India, Bharti Airtel, TBO Tek, Data Patterns (India), Suven Pharmaceuticals, and C.E. Info Systems.

Despite the recent underperformance, Indian share valuations remain high. Goldman Sachs acknowledges that this elevated valuation has been a frequent concern for investors. The firm noted that India's Price to Earnings (P/E) ratio currently sits at 23 times the 12-month forward valuations, making it the costliest market among emerging economies.

Looking ahead, the firm anticipates a moderate de-rating of 5% in its base case and 9% in its bear-case scenario over the next two years. The P/E valuation premium for India compared to the rest of Asia has decreased from its peak of 85-90% over the past two years to approximately 45% at present, approaching the 20-year average of 35%.

Goldman Sachs' analysis indicates that historically, when the P/E premium is at current levels, Indian markets tend to perform modestly better than their Asian counterparts in the subsequent six to twelve months. As investors weigh the potential for recovery against high valuations, the coming months will be pivotal for the direction of Indian equities.

New Age IPOs Struggle Amid Declining Investor Sentiment
New Age IPOs Struggle Amid Declining Investor Sentiment
Investor enthusiasm for new-age IPOs wanes as Lenskart's disappointing debut affects other offerings, including Groww and PhysicsWallah.
|
Ongoing Conflict: Israeli Military Actions and Humanitarian Crisis in Gaza
Ongoing Conflict: Israeli Military Actions and Humanitarian Crisis in Gaza
As Israeli operations persist, Gaza faces a humanitarian crisis with children out of school and minimal aid deliveries.
|
Rahul Gandhi Accuses BJP of Vote Manipulation in Several States
Rahul Gandhi Accuses BJP of Vote Manipulation in Several States
Congress leader Rahul Gandhi claims BJP engaged in vote theft across multiple states, alleging electoral fraud in Haryana, Madhya Pradesh, and Chhattisgarh.
|
India cyber fraud: Dr Reddy’s loses ₹2.16 crore in email impersonation scam
India cyber fraud: Dr Reddy’s loses ₹2.16 crore in email impersonation scam
Dr Reddy’s Laboratories in India has lost ₹2.16 crore after cyber criminals allegedly hacked email exchanges with Group Pharmaceuticals and diverted a payment, according to a police complaint.
|
Congress Clarifies After Shashi Tharoor's Remarks on LK Advani
Congress Clarifies After Shashi Tharoor's Remarks on LK Advani
Shashi Tharoor's comments on LK Advani prompt Congress to clarify that his views are personal, not reflecting the party's stance.
|